XML 15 R5.htm IDEA: XBRL DOCUMENT v3.7.0.1
CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2017
Mar. 31, 2016
Statement of Cash Flows [Abstract]    
Net Income (Loss) Available to Common Stockholders, Basic $ 7,084 $ 4,571
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 3,847 3,734
Provision for losses on accounts receivable 389 523
Stock-based compensation expense 836 1,297
Deferred income tax (benefit) expense 162 379
Amortization of deferred financing costs 203 221
Accretion of discount on convertible subordinated notes 1,037 927
Loss on early extinguishment of debt 0 567
Net (gain) loss on sale and disposal of other assets 155 (187)
Changes in operating assets and liabilities that provided (required) cash:    
Accounts and preneed receivables 303 (479)
Inventories and other current assets 1,976 (727)
Intangible and other non-current assets 80 230
Preneed funeral and cemetery trust investments (1,404) 7,560
Accounts payable (2,778) (1,755)
Accrued and other liabilities (6,142) 344
Deferred preneed funeral and cemetery revenue 1,308 (568)
Deferred preneed funeral and cemetery receipts held in trust 1,103 (6,404)
Net cash provided by operating activities 8,159 10,233
Cash flows from investing activities:    
Acquisitions and land for new construction 0 (2,685)
Net proceeds from the sale of other assets 0 555
Capital expenditures (3,730) (3,595)
Net cash used in investing activities (3,730) (5,725)
Cash flows from financing activities:    
Borrowings from the revolving credit facility 18,800 11,500
Payments against the revolving credit facility (21,400) (50,100)
Payments against the revolving credit facility 0 39,063
Payments against the term loan (2,813) (2,813)
Payments on other long-term debt and obligations under capital leases (368) (321)
Payments on contingent consideration recorded at acquisition date (101) 0
Proceeds from the exercise of stock options and employee stock purchase plan contributions 315 228
Taxes paid on restricted stock vestings and exercise of non-qualified options (509) (491)
Dividends paid on common stock (833) (415)
Payment of loan origination costs related to the credit facility 0 (717)
Excess tax deficiency of equity compensation 0 (106)
Net cash used in financing activities (6,909) (4,172)
Net increase (decrease) in cash and cash equivalents (2,480) 336
Cash and cash equivalents at beginning of period 3,286  
Cash and cash equivalents at end of period $ 806 $ 871